Identification of synovial fluid microRNA signature in knee osteoarthritis: differentiating early- and late-stage knee osteoarthritis

Osteoarthritis and Cartilage

Volumn 24, Issue 9, 2016, Pages 1577-1586

  Li, Y H ^a   Tavallaee, G ^a   Tokar, T ^b   Nakamura, A ^a   Sundararajan, K ^c   Weston, A ^c   Sharma, A ^a   Mahomed, N N ^c   Gandhi, R ^c   Jurisica, I ^b   Kapoor, M ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Articular cartilage; Biomarker; miRNA; Osteoarthritis; Synovial fluid; Synovium

Indexed keywords

INTERLEUKIN 1BETA; MICRORNA; MICRORNA 186 5P; MICRORNA 23A 3P; MICRORNA 24; MICRORNA 24 3P; MICRORNA 27A 3P; MICRORNA 27B 3P; MICRORNA 29; MICRORNA 29C 3P; MICRORNA 34A; MICRORNA 34A 5P; MICRORNA 378A 5P; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY STAGE KNEE OSTEOARTHRITIS; GENDER; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; LATE STAGE KNEE OSTEOARTHRITIS; PRIORITY JOURNAL; QK GENE; RC3H1 GENE; REAL TIME POLYMERASE CHAIN REACTION; SYNOVIAL FLUID LEVEL; VALIDATION STUDY; SYNOVIAL FLUID; SYNOVIUM;

HUMANS; MICRORNAS; OSTEOARTHRITIS, KNEE; REAL-TIME POLYMERASE CHAIN REACTION; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 84969512913     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2016.04.019     Document Type: Article

References (24)

1. 1 Hunter, D.J., Schofield, D., Callander, E., The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 10:7 (2014), 437–441.
2. 2 Roemer, F.W., Eckstein, F., Hayashi, D., Guermazi, A., The role of imaging in osteoarthritis. Best Pract Res Clin Rheumatol 28:1 (2014), 31–60.
3. 3 Felson, D.T., Hodgson, R., Identifying and treating preclinical and early osteoarthritis. Rheum Dis Clin North Am 40:4 (2014), 699–710.
4. 4 Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:2 (2004), 281–297.
5. 5 Ceribelli, A., Yao, B., Dominguez-Gutierrez, P.R., Nahid, M.A., Satoh, M., Chan, E.K., MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther, 13(4), 2011, 229.
6. 6 Siddeek, B., Inoubli, L., Lakhdari, N., Rachel, P.B., Fussell, K.C., Schneider, S., et al. MicroRNAs as potential biomarkers in diseases and toxicology. Mutat Res Genet Toxicol Environ Mutagen 764–765 (2014), 46–57.
7. 7 Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., et al. The microRNA spectrum in 12 body fluids. Clin Chem 56:11 (2010), 1733–1741.
8. 8 Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:30 (2008), 10513–10518.
9. 9 Ge, Q., Zhou, Y., Lu, J., Bai, Y., Xie, X., Lu, Z., miRNA in plasma exosome is stable under different storage conditions. Molecules (Basel, Switzerland) 19:2 (2014), 1568–1575.
10. 10 Bernard, N.J., Osteoarthritis: circulating miRNAs-early osteoarthritis biomarkers. Nat Rev Rheumatol, 10(4), 2014, 197.
11. 11 Beyer, C., Zampetaki, A., Lin, N.Y., Kleyer, A., Perricone, C., Iagnocco, A., et al. Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis, 74(3), 2015, e18.
12. 12 Borgonio Cuadra, V.M., Gonzalez-Huerta, N.C., Romero-Cordoba, S., Hidalgo-Miranda, A., Miranda-Duarte, A., Altered expression of circulating microRNA in plasma of patients with primary osteoarthritis and in silico analysis of their pathways. PLoS One, 9(6), 2014, e97690.
13. 13 Murata, K., Yoshitomi, H., Tanida, S., Ishikawa, M., Nishitani, K., Ito, H., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther, 12(3), 2010, R86.
14. 14 Jayabalan, P., Sowa, G.A., The development of biomarkers for degenerative musculoskeletal conditions. Discov Med 17:92 (2014), 59–66.
15. 15 Kellgren, J.H., Lawrence, J.S., Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:4 (1957), 494–502.
16. 16 Brown, K.R., Otasek, D., Ali, M., McGuffin, M.J., Xie, W., Devani, B., et al. NAViGaTOR: network analysis, visualization and graphing Toronto. Bioinformatics 25:24 (2009), 3327–3329.
17. 17 Xu, J.F., Zhang, S.J., Zhao, C., Qiu, B.S., Gu, H.F., Hong, J.F., et al. Altered microRNA expression profile in synovial fluid from patients with knee osteoarthritis with treatment of hyaluronic acid. Mol Diagn Ther 19:5 (2015), 299–308.
18. 18 Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.P., Fahmi, H., Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7:1 (2011), 33–42.
19. 19 Akhtar, N., Rasheed, Z., Ramamurthy, S., Anbazhagan, A.N., Voss, F.R., Haqqi, T.M., MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 62:5 (2010), 1361–1371.
20. 20 Tardif, G., Hum, D., Pelletier, J.P., Duval, N., Martel-Pelletier, J., Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord, 10, 2009, 148.
21. 21 Shen, J., Li, S., Chen, D., TGF-beta signaling and the development of osteoarthritis. Bone Res, 2, 2014, 14002.
22. 22 Scanzello, C.R., Umoh, E., Pessler, F., Diaz-Torne, C., Miles, T., Dicarlo, E., et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 17:8 (2009), 1040–1048.
23. 23 Vinuesa, C.G., Cook, M.C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill, K.M., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:7041 (2005), 452–458.
24. 24 Aberg, K., Saetre, P., Jareborg, N., Jazin, E., Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA 103:19 (2006), 7482–7487.